>Crestor – By chance would you know what the economics are for Shionogi (Is it a straight royalty/capped/etc.)?< It’s unusual for Big Pharma to allow this kind of information to be disclosed, so the chances are it hasn’t been. >My interest in Shionogi is for another drug not yet approved< Pirfenidone, perchance? :-)